In mice of nonautoimmune-prone background, PTPN22 ablation increases interferon (IFN)-α-induced lupus-like disease [127], while in lupus-prone mice, it exacerbates the severity of systemic autoimmunity [128,129]. The gene discussed is PTPN22; the disease is systemic lupus erythematosus.